Lyka Labs jumped 6.22% to Rs 56.35 at 12:15 IST on BSE, with the stock extending recent gains.
Meanwhile, the S&P BSE Sensex was up 59.58 points, or 0.19% at 31,963.98. The S&P BSE Small-Cap index was up 23.91 points, or 0.15% at 16,023.79.
On the BSE, 1.56 lakh shares were traded on the counter so far as against the average daily volumes of 30,801 shares in the past one quarter. The stock had hit a high of Rs 58 and a low of Rs 53 so far during the day. The stock had hit a 52-week high of Rs 78 on 21 July 2016 and a 52-week low of Rs 38.65 on 28 June 2017.
The stock had outperformed the market over the past one month till 20 July 2017, advancing 13.96% compared with the Sensex's 1.94% rise. The scrip had, however, underperformed the market over the past one quarter advancing 1.73% as against the Sensex's 8.44% rise. The scrip had also underperformed the market over the past one year declining 30.56% as against the Sensex's 14.29% rise.
The small-cap company has equity capital of Rs 22.04 crore. Face value per share is Rs 10.
Shares of Lyka Labs rose 21.44% in seven trading sessions to its current market price of Rs 56.35, from a close of Rs 46.40 on 12 July 2017.
Lyka Labs reported consolidated net profit of Rs 1.84 crore in Q4 March 2017, compared with net loss of Rs 11.99 crore in Q4 March 2016. Net sales fell 11.6% to Rs 30.60 crore in Q4 March 2017 over Q4 March 2016.
Lyka Labs is engaged in the manufacturing of pharmaceutical formulations and active pharmaceutical ingredients (APIs) across various therapeutic segments.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
